We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Stroke Telemedicine for Arizona Rural Residents Trial (STARR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00829361
Recruitment Status : Completed
First Posted : January 27, 2009
Last Update Posted : November 25, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
The STARR network registry consists of a 4 spoke 1 hub system. Which will consist of prospective collection, recording, and regular analysis of telestroke patient consultation and care data for the purpose of quality measure assessment and improvement and benchmarking against other national and international telestroke programs.

Condition or disease Intervention/treatment
Stroke Cerebral Infarction Vascular Diseases Brain Ischemia Brain Infarction Brain Diseases Cerebrovascular Disorders Other: Telemedicine

  Show Detailed Description

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 447 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Stroke Telemedicine for Arizona Rural Residents Trial
Study Start Date : October 2008
Primary Completion Date : October 2011
Study Completion Date : January 2012
Arms and Interventions

Arm Intervention/treatment
Telemedicine Other: Telemedicine
Two way site independent audio/video telemedicine system with DICOM.

Outcome Measures

Primary Outcome Measures :
  1. To assess the numbers of patients who receive thrombolytics and the time to treatment in patients evaluated by telemedicine [ Time Frame: 90 days ]

Secondary Outcome Measures :
  1. To assess the functional outcomes of acute stroke subjects by Barthel index and Modified Rankin Scale [ Time Frame: 90 days ]
  2. To assess the rate of intracranial hemorrhage post thrombolysis [ Time Frame: 90 days ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 120 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients presenting to Rural Emergency Department within 12 hours of acute stroke symptom onset.
  • Written informed consent.

Exclusion Criteria:

  • Unlikely to complete study through 90-day follow-up.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00829361

United States, Arizona
Mayo Clinic Hospital
Phoenix, Arizona, United States, 85054
Sponsors and Collaborators
Mayo Clinic
Arizona Department of Health Services
Principal Investigator: Bart M. Demerschalk, M.D. Mayo Clinic
Principal Investigator: Bentley J. Bobrow, M.D. Mayo Clinic
Study Director: Dwight D Channer, MS Mayo Clinic
More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00829361     History of Changes
Other Study ID Numbers: 08-005156
First Posted: January 27, 2009    Key Record Dates
Last Update Posted: November 25, 2015
Last Verified: November 2015

Keywords provided by Mayo Clinic:
Acute stroke
Cerebral Infarction
Vascular diseases
brain ischemia
brain infarction
brain diseases
cerebrovascular disorders

Additional relevant MeSH terms:
Vascular Diseases
Cerebral Infarction
Brain Diseases
Cerebrovascular Disorders
Brain Ischemia
Brain Infarction
Central Nervous System Diseases
Nervous System Diseases
Cardiovascular Diseases
Pathologic Processes